Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV

OBJECTIVE: To evaluate immunogenicity and reactogenicity of yellow fever (YF) vaccine in people with HIV (PWH) compared to HIV-uninfected controls. DESIGN: In this longitudinal interventional trial (NCT03132311), PWH with CD4(+) cell count ≥200 cells/μl and controls, aged 18–59, without a previous h...

Descripción completa

Detalles Bibliográficos
Autores principales: Motta, Edwiges, Camacho, Luiz Antonio B., Cunha, Marcelo, de Filippis, Ana Maria Bispo, Lima, Sheila M.B., Costa, Marcellus, Pedro, Luciana, Cardoso, Sandra W., Cortes, Fernanda Heloise, Giacoia-Gripp, Carmem B.W., Morata, Michelle, Nazer, Sandro, Moreira, Ronaldo Ismério, de Oliveira Souza, Marta Cristina, Mendes, Ygara S., de Souza Azevedo, Adriana, dos Santos Alvez, Nathalia, Grinsztejn, Beatriz, Coelho, Lara E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653289/
https://www.ncbi.nlm.nih.gov/pubmed/37650759
http://dx.doi.org/10.1097/QAD.0000000000003696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653289/
https://www.ncbi.nlm.nih.gov/pubmed/37650759
http://dx.doi.org/10.1097/QAD.0000000000003696

Ejemplares similares